SHE · Healthcare

SMO ClinPlus Co. Ltd. (301257)

Diagnostics & Research

SMO ClinPlus Co. Ltd. (301257) is listed on SHE in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-29, reported market cap is $4.44B, P/E ratio is 41.07, net margin is 14.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Key metrics for 301257

Market cap
$4.44B
P/E ratio
41.07
Gross profit (TTM)
$206.17M
Net margin
14.8%

SMO ClinPlus Co. Ltd. (301257) — FAQ

What is SMO ClinPlus Co. Ltd.'s market cap?

SMO ClinPlus Co. Ltd. (301257) has a reported market cap of $4.44B (data as of 2026-03-29).

What is 301257's P/E ratio?

The price-to-earnings (P/E) ratio for SMO ClinPlus Co. Ltd. (301257) is 41.07 (data as of 2026-03-29).

Does SMO ClinPlus Co. Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for SMO ClinPlus Co. Ltd. (301257). Check the MyAverix Finance app for the latest dividend data.

What sector is SMO ClinPlus Co. Ltd. in?

SMO ClinPlus Co. Ltd. (301257) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is 301257 listed on?

301257 is listed on SHE.

What is SMO ClinPlus Co. Ltd.'s net margin?

SMO ClinPlus Co. Ltd. (301257) reports a net margin of 14.8% (data as of 2026-03-29).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

App Store Google Play